Mirum Pharmaceuticals Opens Below IPO Price
Mirum Pharmaceuticals (NASDAQ: MIRM) made its public debut Thursday morning, opening at $13 after being priced at $15 per share.
The shares are listed on the Nasdaq and trading under the symbol MIRM.
Mirum Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
Invest in IPO shares before the stock hits the market with ClickIPO. Check it out here
Citigroup, Evercore ISI and Guggenheim Securities are acting as joint book-running managers for the offering. Raymond James is acting as lead manager. Roth Capital Partners is acting as co-manager.
Related Links:
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
